The median overall survival in the ID8luc-Trp53−/−Ctrl group was 146 days after tumour cell inoculation, compared to 184 days in the Cx3cl1+ group (P = 0.0049; Fig. 4G). Here, CX3CL1 is linked to neoplasm.